Lipid-lowering drugs.
Charlotte
Nicholls
N
Guy's & St Thomas' Hospital.
Sani
Mojgan
M
D000924:Anticholesteremic Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003327:Coronary Disease / Q000209:etiology; D000069438:Ezetimibe; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D009525:Niacin / Q000627:therapeutic use; D012307:Risk Factors; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D001384:Azetidines; D015525:Fatty Acids, Omega-3; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002792:Cholestyramine Resin; D009525:Niacin; D000069438:Ezetimibe